Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

Exclusion Criteria

• •Pregnant or lactating patients;
• •Inability or refusal to have at least one peripheral intravenous line for intravenous access;
• •From assays obtained \<2 weeks prior to study enrollment（ULN：the upper limit of normal value ）:Bilirubin\>1.5\*ULN,AST/ALT \>2.5 \* ULN, Albumin\< 3 g/dl, GGT \> 2.5 x ULN if ALP\> 2.5 x ULN, Creatinine\>1.5\*ULN or creatinine clearance \<60ml/min；
• •Patients with a history of allergic reaction to this drugs or its analogues；
• •patients with poor compliance;
• •Acute major illness